In 2021, the Canada Sexually Transmitted Disease Testing Market was estimated to be worth USD 205.9 million. The market is expected to increase at a CAGR of 4.1% during the forecast period, from USD 233.6 million in 2022 to USD 310.5 million in 2029.

In 2021, the Canada Sexually Transmitted Disease Testing Market was estimated to be worth USD 205.9 million. The market is expected to increase at a CAGR of 4.1% during the forecast period, from USD 233.6 million in 2022 to USD 310.5 million in 2029.